3 October, 2018 – Successful IPO of MedinCell  

PRESS RELEASE Jacou, 19 July 2018 European Investment Bank reiterates support for MedinCell in presence of French Minister for European Affairs Nathalie Loiseau During the visit of French Minister for European Affairs Nathalie Loiseau to MedinCell today, the European Investment Bank (EIB) reiterated its support for MedinCell in the follow-up to the EUR 20m loan […]

EIB lends EUR 20m to innovative company MedinCell Luxembourg, 22 March 2018 This EUR 20m loan will enable MedinCell to develop new controlled, long-acting injectable treatments to significantly enhance patient care and quality of life. This is the 120th operation approved in France under the Investment Plan for Europe, commonly known as the Juncker Plan, […]

Press Release December 7 MedinCell receives grant to develop long-acting injectable contraceptive French company MedinCell has been awarded $3.5M grant from the Bill & Melinda Gates Foundation to advance development of 6-month acting injectable contraceptive candidate with the company’s BEPO® technology. In the long-term, this program could facilitate access to contraception for millions of women […]

MedinCell Announces Investment by CM-CIC Innovation Paris, October 19, 2017. MedinCell, a pharmaceutical company developing a new generation of long-acting injectable medicines using its BEPO technology, announced that CM-CIC Innovation has made an investment into the Company. The Montpellier, France based company was previously 100% owned by its founders and employees. As part of the […]